#ASH12 - Twitter Hashtag

OjiactualTTV @0jiactual

over 2 years ago

I carry a big stick! https://t.co/OhhYJBdWjJ #tarkov #eft #escapefromtarkov #ash12

0

2

0

42

Andrew Kuykendall MD @KuykendallMd

over 2 years ago

Things you DID hear at #ASH12 that you will also hear at #ASH23. “Is spleen volume response really the best we can do as an endpoint for MF?”

1

7

2

1

555

Andrew Kuykendall MD @KuykendallMd

over 2 years ago

Things at #ASH23 you didn’t overhear at #ASH12. “Ok, you have to retweet my article because I hashtagged you.”

3

11

0

883

Tania Jain @TaniaJain11

over 2 years ago

#ASH23 this is relatable .. Facebook reminded me earlier today of my first #ASH travel to Atlanta in #ASH12 as PGY2

David Steensma, MD @DavidSteensma

over 2 years ago

First time I heard of @ASH_hematology, I was an intern & overheard a group of fellows talking about “going to ASH.” I had no idea what they meant. It amused me to learn what it was. “Wait - they really call a society ‘ASH’’, like the stuff left over after a campfire?” #ASH23😝

DavidSteensma's tweet photo. First time I heard of @ASH_hematology, I was an intern & overheard a group of fellows talking about “going to ASH.” I had no idea what they meant. It amused me to learn what it was. “Wait - they really call a society ‘ASH’’, like the stuff left over after a campfire?” #ASH23😝 https://t.co/bnwDQpI75Y

3

83

6

0

13K

1

21

1

0

3K

Lai (Linda) Chan @LindaCPhD

over 3 years ago

@Dr_AmerZeidan @ASH_hematology My first meeting was #ASH12 in Atlanta

0

1

0

C. Ola Landgren, M.D. @DrOlaLandgren

over 3 years ago

Talquetamab - the next target for bi-specific antibodies in myeloma. GPRC5DxCD3. #ASH12 #mmsm

0

2

0

The Stache @TheStacheGuyTV

about 4 years ago

No Fear https://t.co/ud702iLpDP #military #PCGaming #twitch #twitchaffiliate #tarkov #eft #FPS #ash12

0

1

0

BuffNerdGaming

@BuffNerdGaming1

about 4 years ago

Oh you have your new Vanguard meta smg that everyone in the games uses? ASh-12 says hello. #ash12 #hellothere #Warzone

1

14

1

0

BuffNerdGaming

@BuffNerdGaming1

over 4 years ago

Revisiting the most versatile weapon in Modern Warfare, the ODEN aka ASh-12 aka shAK-12! Good for close and long ranges, gotta love MW weapons! @BigMikeMW with the edit! #ModernWarfare #shAK12 #ash12 @InfinityWard @CallofDuty https://t.co/bx9wwU8GEl

BuffNerdGaming1's tweet photo. Revisiting the most versatile weapon in Modern Warfare, the ODEN aka ASh-12 aka shAK-12! Good for close and long ranges, gotta love MW weapons! @BigMikeMW with the edit! #ModernWarfare #shAK12 #ash12 @InfinityWard @CallofDuty
https://t.co/bx9wwU8GEl https://t.co/XdNPdL5LSQ

1

5

1

0

Robin Tuohy @IMFsupport

over 4 years ago

Video Interview with @SagarLonialMD. With S isomer, may result in less adverse events! #ASH12 #IMFASH12 Iberdomide in Combination with Dexamethasone in Pts with Relapsed/Refractory Multiple Myeloma https://t.co/tv54moI5SH via @IMFmyeloma

1

2

1

0

Hayder Saeed, MD @HayderSaeed_MD

over 4 years ago · Atlanta

Dinner with the fellows and the Moffitt team #ash12 @AkritiGJain @TheOncDoc @SavanShahMD

1

10

0

UT MD Anderson

@UTMDAnderson

over 4 years ago

Findings from Dr. Sattva Neelapu and Dr. Jason Westin show efficacy of moving CAR T cell therapy to earlier lines of therapy. Read the latest results from the ZUMA-5, ZUMA-12 and the ZUMA-7 clinical trials: https://t.co/5EFge8WIkP #ASH12 @lymphoma_doc #EndCancer

0

20

10

0

Charlotte Pawlyn @_DrCP

over 4 years ago

Do you remember when you joined Twitter? I do! #MyTwitterAnniversary #ASH12 #ASH21 #mmsm

1

6

1

0

@MyelomaTeacher - Cindy Chmielewski @MyelomaTeacher

over 4 years ago

#ASHMemories -my first #ASH12 This is how I feel now and we haven’t even started the official program #ASH21 #MMSM #HealthTreeMM

MyelomaTeacher's tweet photo. #ASHMemories -my first #ASH12 This is how I feel now and we haven’t even started the official program #ASH21 #MMSM #HealthTreeMM https://t.co/wBnZQr2K8W

2

15

1

0

@MyelomaTeacher - Cindy Chmielewski @MyelomaTeacher

over 4 years ago

See you bright and early! I hope there is coffee. #Ash12 #mmsm # HealthTreeMM

PeerView

@PeerView

over 4 years ago

Tweet your questions in advance of the multiple myeloma symposium preceding #ASH21 on December 10 at 7:00 AM! https://t.co/e2QsjE6DND #PeerView

0

2

0

1

4

2

0

Tania Jain @TaniaJain11

over 4 years ago

Don’t have a picture but my first was #ASH12 Atlanta, PGY2 Internal Medicine @waynestate, presented a poster w/ @abhinav_deol ..have never missed presenting since (or being a part of one) - thanks to @kgowinDO @mpdrc @Rfonsi1 @JeannePalmerMD @DrMiguelPerales @GunjanLShah #ASH21

ASH @ASH_hematology

over 4 years ago

We’re looking forward to welcoming you to #ASH21! What year was your first annual meeting? RehASH the fun with some #ThrowbackThursday photos ⏳ (& make sure to include #ASH21 in your own #TBT!)

ASH_hematology's tweet photo. We’re looking forward to welcoming you to #ASH21! What year was your first annual meeting? RehASH the fun with some #ThrowbackThursday photos ⏳

(& make sure to include #ASH21 in your own #TBT!) https://t.co/ZKRJ9i2b6x

17

60

5

0

11

1

0

Al-Ola A Abdallah MD (USMIRC)

@Abdallah81MD

over 4 years ago

In VTd group, the 1-year sustained MRD-negativity rate was significantly higher with DARA vs OBS 35.7% vs 21.4% but no difference was observed in the 2-year sustained MRD rate 11.3% vs 13.0% #mmsm #myeloma #ASH12

1

0

Mike Thompson, MD, PhD, FASCO

@mtmdphd

almost 5 years ago

ID Signif Barriers 2 Accrual 2 @theNCI MM #ClinicalTrials - @mweissmdphd et al. @SJ_OncBiostats @nsc_natalie @EdwardGorak @MileHighMyeloma @IMFjimMYELOMA @Myeloma_Doc @VincentRK @MorieGertz Munshi et al. #ASH12 Abst 3165 https://t.co/i4zO7ktqHJ #mmsm

mtmdphd's tweet photo. ID Signif Barriers 2 Accrual 2 @theNCI MM #ClinicalTrials - @mweissmdphd et al. @SJ_OncBiostats @nsc_natalie @EdwardGorak @MileHighMyeloma @IMFjimMYELOMA @Myeloma_Doc @VincentRK @MorieGertz Munshi et al. #ASH12 Abst 3165 https://t.co/i4zO7ktqHJ #mmsm https://t.co/ws02PjfUKI

0

3

1

0

Bawsse @Bawssettv

over 5 years ago

This gun and me are going places. #ash12 #EscapefromTarkov

0

4

0

Mike Thompson, MD, PhD, FASCO

@mtmdphd

about 6 years ago

Identification of Significant Barriers to Accrual (BtA) to @theNCI Sponsored Multiple Myeloma – Clinical Trials (MM-CT): A Step towards Improving Accrual to #ClinicalTrials - @mweissthedacare et al. #ASH12 Abstract 3165 https://t.co/i4zO7ktqHJ #mmsm #caxtx #ctsm

1

2

0

Top Tweets for #ASH12

Last Seen Hashtags on Sotwe

Trends for you

Most Popular Users